Skip to content

Outset Medical, Inc. OM Fair Value Adjustment Of Warrants

Fair Value Adjustment Of Warrants at other companies

CorMedix logo
CorMedixCRMD
$3.55M

Other financials

Income statement

See full
Revenue$27.9M-6.3%
Gross profit$12.1M+9.3%
Operating income-$16.9M-3.2%
Net income-$19.0M+26.4%
EPS (diluted)-$1.03+71.9%

Balance sheet

See full
Cash & equivalents$30.6M-59.7%
Total debt$101.6M+3.5%
Total equity$111.7M-34.3%
Total assets$249.5M-17.2%

Cash flow

See full
Operating cash flow-$12.8M+50.0%
CapEx$65.0K-47.2%
Free cash flow-$12.9M+49.9%

Valuation

See full
Market cap$80.08M-75.5%
Enterprise value$151.13M-61.9%
P/S0.7×-2.1×

Profitability

See full
Gross margin40.6%+4.7pp
Operating margin-57.2%-12.9pp
Net margin-63.7%-16.7pp
FCF margin-29.1%-11.5pp

Returns & leverage

See full
Return on equity-53.2%-14.8pp
Debt / equity0.9×+0.3×
Current ratio6.3×-2.1×

Where this comes from

Reported directly by Outset Medical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FairValueAdjustmentOfWarrants.

The official record: Outset Medical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Outset Medical, Inc.'s fair value adjustment of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Outset Medical, Inc.'s fair value adjustment of warrants?
Outset Medical, Inc. (OM) reported fair value adjustment of warrants of $0 in Q1 2026.
How has Outset Medical, Inc.'s fair value adjustment of warrants changed year-over-year?
Outset Medical, Inc.'s fair value adjustment of warrants decreased by 100.0% year-over-year, from $4.37M to $0.
What does fair value adjustment of warrants mean?
This metric reflects the non-cash gain or loss resulting from the periodic revaluation of outstanding warrants to their current fair market value. Because warrants are often classified as liabilities, changes in the company's stock price or volatility assumptions directly impact this valuation. It is essential for investors to isolate this item to understand the underlying operational performance versus non-operating accounting adjustments.